Cargando…

Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review

Prevalence data of respiratory diseases (RDs) in Central Asia (CA) and Russia are contrasting. To inform future research needs and assist government and clinical policy on RDs, an up-to-date overview is required. We aimed to review the prevalence and economic burden of RDs in CA and Russia. PubMed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabyshova, Aizhamal, Emilov, Berik, Postma, Maarten J., Chavannes, Niels H., Sooronbaev, Talant, van Boven, Job F. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602368/
https://www.ncbi.nlm.nih.gov/pubmed/33066700
http://dx.doi.org/10.3390/ijerph17207483
_version_ 1783603661918699520
author Tabyshova, Aizhamal
Emilov, Berik
Postma, Maarten J.
Chavannes, Niels H.
Sooronbaev, Talant
van Boven, Job F. M.
author_facet Tabyshova, Aizhamal
Emilov, Berik
Postma, Maarten J.
Chavannes, Niels H.
Sooronbaev, Talant
van Boven, Job F. M.
author_sort Tabyshova, Aizhamal
collection PubMed
description Prevalence data of respiratory diseases (RDs) in Central Asia (CA) and Russia are contrasting. To inform future research needs and assist government and clinical policy on RDs, an up-to-date overview is required. We aimed to review the prevalence and economic burden of RDs in CA and Russia. PubMed and EMBASE databases were searched for studies that reported prevalence and/or economic burden of RDs (asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, interstitial lung diseases (ILD), lung cancer, pulmonary hypertension, and tuberculosis (TB)) in CA (Kyrgyzstan, Uzbekistan, Tajikistan, Kazakhstan, and Turkmenistan) and Russia. A total of 25 articles (RD prevalence: 18; economics: 7) were included. The majority (n = 12), mostly from Russia, reported on TB. TB prevalence declined over the last 20 years, to less than 100 per 100,000 across Russia and CA, yet in those, multidrug-resistant tuberculosis (MDR-TB) was alarming high (newly treated: 19–26%, previously treated: 60–70%). COPD, asthma (2–15%) and ILD (0.006%) prevalence was only reported for Russia and Kazakhstan. No studies on cystic fibrosis, lung cancer and pulmonary hypertension were found. TB costs varied between US$400 (Tajikistan) and US$900 (Russia) for drug-susceptible TB to ≥US$10,000 for MDR-TB (Russia). Non-TB data were scarce and inconsistent. Especially in CA, more research into the prevalence and burden of RDs is needed.
format Online
Article
Text
id pubmed-7602368
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76023682020-11-01 Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review Tabyshova, Aizhamal Emilov, Berik Postma, Maarten J. Chavannes, Niels H. Sooronbaev, Talant van Boven, Job F. M. Int J Environ Res Public Health Review Prevalence data of respiratory diseases (RDs) in Central Asia (CA) and Russia are contrasting. To inform future research needs and assist government and clinical policy on RDs, an up-to-date overview is required. We aimed to review the prevalence and economic burden of RDs in CA and Russia. PubMed and EMBASE databases were searched for studies that reported prevalence and/or economic burden of RDs (asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, interstitial lung diseases (ILD), lung cancer, pulmonary hypertension, and tuberculosis (TB)) in CA (Kyrgyzstan, Uzbekistan, Tajikistan, Kazakhstan, and Turkmenistan) and Russia. A total of 25 articles (RD prevalence: 18; economics: 7) were included. The majority (n = 12), mostly from Russia, reported on TB. TB prevalence declined over the last 20 years, to less than 100 per 100,000 across Russia and CA, yet in those, multidrug-resistant tuberculosis (MDR-TB) was alarming high (newly treated: 19–26%, previously treated: 60–70%). COPD, asthma (2–15%) and ILD (0.006%) prevalence was only reported for Russia and Kazakhstan. No studies on cystic fibrosis, lung cancer and pulmonary hypertension were found. TB costs varied between US$400 (Tajikistan) and US$900 (Russia) for drug-susceptible TB to ≥US$10,000 for MDR-TB (Russia). Non-TB data were scarce and inconsistent. Especially in CA, more research into the prevalence and burden of RDs is needed. MDPI 2020-10-14 2020-10 /pmc/articles/PMC7602368/ /pubmed/33066700 http://dx.doi.org/10.3390/ijerph17207483 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tabyshova, Aizhamal
Emilov, Berik
Postma, Maarten J.
Chavannes, Niels H.
Sooronbaev, Talant
van Boven, Job F. M.
Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review
title Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review
title_full Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review
title_fullStr Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review
title_full_unstemmed Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review
title_short Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review
title_sort prevalence and economic burden of respiratory diseases in central asia and russia: a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602368/
https://www.ncbi.nlm.nih.gov/pubmed/33066700
http://dx.doi.org/10.3390/ijerph17207483
work_keys_str_mv AT tabyshovaaizhamal prevalenceandeconomicburdenofrespiratorydiseasesincentralasiaandrussiaasystematicreview
AT emilovberik prevalenceandeconomicburdenofrespiratorydiseasesincentralasiaandrussiaasystematicreview
AT postmamaartenj prevalenceandeconomicburdenofrespiratorydiseasesincentralasiaandrussiaasystematicreview
AT chavannesnielsh prevalenceandeconomicburdenofrespiratorydiseasesincentralasiaandrussiaasystematicreview
AT sooronbaevtalant prevalenceandeconomicburdenofrespiratorydiseasesincentralasiaandrussiaasystematicreview
AT vanbovenjobfm prevalenceandeconomicburdenofrespiratorydiseasesincentralasiaandrussiaasystematicreview